Our data revealed that the overexpression of ACSM3 inhibited cell proliferation, migration, and invasion in ovarian cancer mediated by the suppression of the Integrin β1/AKT signaling pathway in vitro. This evidence concerns the gene ACSM3 and ovarian cancer.